Vanda Pharmaceuticals (VNDA) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to -$2.39.
- Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) fell 255555.56% to -$2.39 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.73, marking a year-over-year decrease of 103030.3%. This contributed to the annual value of -$3.74 for FY2025, which is 103333.33% down from last year.
- Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$2.39 in Q4 2025, which was down 255555.56% from -$0.38 recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.17 in Q2 2021 and a low of -$2.39 during Q4 2025
- For the 5-year period, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$0.17, with its median value being -$0.02 (2023).
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 140000.0% in 2021, then plummeted by 297976.72% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at $0.12 in 2021, then rose by 0.0% to $0.12 in 2022, then plummeted by 141.67% to -$0.05 in 2023, then plummeted by 80.0% to -$0.09 in 2024, then plummeted by 2555.56% to -$2.39 in 2025.
- Its EPS (Weighted Average and Diluted) was -$2.39 in Q4 2025, compared to -$0.38 in Q3 2025 and -$0.46 in Q2 2025.